Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Aggregation of MBP in chronic demyelination.
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis.
Autophagic myelin destruction by schwann cells during wallerian degeneration and segmental demyelination.
Framework for Assessment of the Usability of Lower-Extremity Robotic Exoskeletal Orthoses.
Effects of Bacille Calmette-GuÉrin after the first demyelinating event in the CNS.
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes.
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
Mitochondrial dysfunction in central nervous system white matter disorders.
Role of Immune Cells in the Course of Central Nervous System Injury: Modulation with Natural Products.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
Multiple sclerosis: managing a complex neurological disease.
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
Method for the systematic reviews on occupational therapy and neurodegenerative diseases.
Modulation of B Cell Regulatory Molecules CD22 and CD72 in Myasthenia Gravis and Multiple Sclerosis.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
Promoting physical activity to control multiple sclerosis from childhood.
Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis.
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]

Pages